You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
Images in paediatrics
Haematohidrosis treated with propranolol: a case report
  1. Franco Ricci1,
  2. Teresa Oranges1,2,
  3. Elio Novembre1,
  4. Maria Luisa Della Bona3,
  5. Giancarlo la Marca3,
  6. Maurizio de Martino1,
  7. Luca Filippi4
  1. 1 Department of Health Sciences, Anna Meyer Children’s University Hospital, University of Florence, Florence, Italy
  2. 2 Department of Dermatology, University of Pisa, Pisa, Italy
  3. 3 Laboratory for Diseases of the Nervous System and Metabolism, Anna Meyer Children’s University Hospital, Florence, Italy
  4. 4 Neonatal Intensive Care Unit, Medical Surgical Feto-Neonatal Department, Anna Meyer Children’s University Hospital, University of Florence, Florence, Italy
  1. Correspondence to Dr Franco Ricci, Department of Health Sciences, Anna Meyer Children’s University Hospital, University of Florence, 50121 Firenze FI, Italy; franco.ricci{at}meyer.it

http://dx.doi.org/10.1136/archdischild-2017-314170

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 15-year-old girl was referred to our hospital in 2015 with a 3-month history of spontaneous mucocutaneous bleeding. Her clinical history showed she had suffered from a major stressful event (Abruzzo earthquake in 2006).

    Initially the bleeding was sporadic, clear and localised to the eyelids, but after a few weeks became darker, more frequent and widespread (figure 1). Before and after the episodes, no signs of wounds or scrapes were observed. The episodes were usually asymptomatic. …

    View Full Text

    Footnotes

    • Contributors FR: diagnosed the disease in the girl, assisted the patient, wrote the first draft of the manuscript and approved the final manuscript as submitted. TO: participated in the clinical assistance of the patient, and reviewed and approved the final manuscript as submitted. EN: participated in the clinical assistance of the patient and approved the final manuscript as submitted. MLDB: contributed to propranolol measurements, contributed to drafting of the manuscript and approved the final manuscript as submitted. GM: responsible for propranolol measurements, contributed to drafting of the manuscript and approved the final manuscript as submitted. MM: participated in the clinical assistance of the patient, and reviewed and approved the final manuscript as submitted. LF: participated in the clinical assistance of the patient, and drafted and approved the final manuscript as submitted.

    • Competing interests None declared.

    • Patient consent Parental/guardian consent obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.